Download Presentation Title * Option 1 Arial 28pt bold

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
Transcript
Role of Folate and DHA in Preterm
Delivery Prevention.
1
What is the right suplemntation?
Folic Acid
Niacin
B1
DHA
Iron
Ca
B6
B2
Zinc
Iodine
Biotin
B12
Vit C
Vit E
2
Prevalence data in Iran
• The prevalence of NTDs at birth varies considerably by country,
geographic zone, ethnic and racial group; it ranges from as high as 1
case in 100 births in some regions of China to about 1 case in 2000
or less in some Scandinavian countries. In many countries the
prevalence is approximately 1 in 1000 births 2
• Previous studies on NTDs have been carried out in some parts
of the Islamic Republic of Iran.
 In Tehran (1969–78), 1.76/1000 new born had NTDs.
 In Hamadan (1991–97) 5.1/1000 and
 In Kordestan 5.5/1000 new born had NTDs 2
• Between 1998 and 2003. The prevalence at birth of NTDs during the
6-year period was therefore 2.87 per 1000 births 2
1.
2.
Verma, I. C. High frequency of neural tube defects in North India. Lancet 1, 879–880 (1978).
La Revue de Sante de la Mediterranee orientale, Vol. 13, N3, 2007
3
Let start with folic acid!!!!
Folate?
Folic acid?
Metafolin???
4
Terminology is a basic(Clinic Pharmacokinet, 2010, AJCN,
2010, REVIEWS IN OBSTETRICS & GYNECOLOGY, 11)
Dietary folate: Naturally occurring nutrient found in foods such as leafy green
vegetables, legumes, egg yolk, liver, and citrus fruit
Folate: Generic of grouprelated compounds
• Essential vit
• Diet/supp
Folic acid
• Synthetic
• Enriched
food/pharma vit
Metafolin
• LMTHF (LMethylfolate)
• Active folate form (FADHF-THF- LMF)
• Plasma/active
MTHFR main in biological processes
5
What is Metafolin®?
 Metafolin® is the calcium salt of the biologically active form of folate 5-MTHF.
 Metafolin® dissociates into calcium and the biologically active folate form 5-MTHF, the
main folate form in maternal and cord blood.
 Unlike folic acid, Metafolin® is directly available without metabolisation.
 Metafolin® is particularly useful in women who cannot optimally metabolise folic acid
due to the MTHFR C677T polymorphism.
6
T enzyme polymorphism
• The methylenetetrahydrofolate reductase (MTHFR) 677C˃T
polymorphism is a risk factor for neural tube defects.
• The T allele produces an enzyme with reduced folate-processing ability.
• The prevalence of the MTHFR 677TT genotype varies across ethnic
groups and regions, ranging from:
• < 2% in West African and American populations18,19 to
• ˃ 35% in northern Chinese and individuals of Mexican decent.18-20
• ≈ 50% in Europe
• Meta-analysis data has shown that mothers or infants with the TT
genotype are at greated odds of having a pregnancy affected by an NTDs
than do those with the CC genotype.21-23
homozygous TT:
heterozygous CT:
wildtype CC:
Enzyme activity reduced by approx. 70%
Enzyme activity reduced by approx. 30%
Enzyme activity not reduced
18Gue´ant-Rodriguez
RM, et al. Am J Clin Nutr 2006; 83:701–7.
LD, Yang Q. Am J Epidemiol 2000; 151:862–77.
S, Wilson RB. J Hum Genet 2003; 48:1–7.
21Yan L, et al. PLoS ONE 2012; 7:e41689.
22Zhang T, et al. PLoS ONE 2013; 8:e59570.
23Yadav U, et al. Metab Brain Dis 2015; 30(1):7–24.
19Botto
20Ogino
7
Metafolin® – ME MTHFR polymorphism
"Geographical
and ethnic variation of the 677C>T allele of 5,10
methylenetetrahydrofolate reductase (MTHFR): findings from
over 7000 new-borns from 16 areas world wide"
Region
ME
CC
57%
CT
34%
J Med Genet 2003;40:619–625
TT
8%
8
J Obstet Gynaecol Can 2015;37(6):534–549
Title of Presentation | DD.MM.YYYY
9
DHA
Docosahexaenoic acid
DHA supply to the foetus and infant
DHA content in forebrains of fetuses & infants
(n=34, preterm and postnatal up to 2 years)
From approx. the 22nd week of
pregnancy there is a rapid brain
growth and large amounts of
DHA need to be deposited in the
child’s growing tissues, which
depends on maternal DHA
supply.
Placebo-controlled study during
lactation:
DHA content of breast milk
increased up to 90% with DHA
supplementation whereas the
DHA content in the control group
decreased by 17%.
•
25Adapted
from Serhan CN, et al. Annu Rev Pathol 2008; 3:279–312.
33Koletzko
35Jensen
B, et al. Acta Paediatr. 2011; 100:1405-15.
et al. Am J Clin Nutr 2000: 71:S292-9S.
11
What are these special FAs?? What is their role anyway?
• LCPUFA are Essential Fatty acids and cannot be synthesized
in the body and therefore they are required from the diet
• They serve important physiological functions in the organism
• NATO workshop: (1) have anti-inflammatory properties; (2) lower serum triglycerides
and cholesterol; and (3) decrease thrombosis and platelet aggregation (J Nut, 89)
• Grey matter expansion, cell membrane, and
neurodevelopment
LCPUFA: The argument
• Several studies has suggested that human evolved on a diet with a
Omega-6/Omega-3 ratio of approximately 1:1
• Today’s lifestyle and alimentation created an imbalance in the
Omega-6/Omega-3 ratio however in current diet it ranges from
10:1 to 25:1
• This imbalance fuels the concerns that today’s diet may be
insufficient to meet Omega-3 FA’s requirements and calls
supplementation
The argument: Pregnancy & meet the need?
• Pregnancy: Increased demand for DHA
• DHA: Preferentially transported to the infant during 3rd
trimester of gestation & coincides with later stages of brain &
retinal maturation, WITH estimated 67–75 mg/day of DHA
accumulated in utero at the same time
• More demand: Expanded RBC mass, placenta, and basic needs
(LOW dietary intake)
• Supply:
 Maternal DHA intake
 Adaptive metabolic mechanisms(increased synthetic capacity to
metabolise alpha LA to DHA
 Preferential use of the DHA stored in adipose tissue
 DHA saved from pregnancy amenorrhea
AJCN, 00, 09, J Nutr, 01, 05, Placenta, 05, Pediatrics, 08
The evidence
PTB & GA
Neurodevelopment and growth
IVF and others (maternal depression)
DHA and PTB: Biological plausibility?
• A high ratio of omega-6 to omega-3 fatty acids will result in
increased proinflammatory eicosanoid production (ie,PGE2 &
PGF2)
• More DHA in diet: Reduction in the production of
proinflammatory eicosanoids and increased production of
prostacyclin (PGI2), which may promote myometrial relaxation
• Omega-3 fatty acids downregulate the production of PGE2 &
PGF2, and may thereby inhibit the parturition process
Clinic ObGyn, 04, AJOG, 06
13 RCTs
Dosing, sources, and means!! Test your
info!!
• Pregnant and lactating: Aim to achieve at least 200-300 mg
DHA/day to support optimal visual and cognitive development
in offspring
• Women advised to achieve fish consumption equal to
200 mg/day DHA intake rather than merely relying on the
number of servings of fish
• A minority of women achieve this level of DHA: 1999-2002
National Health and Nutrition Examination (NHANES), mean
DHA intake 73 mg/day among pregnant women, and
62 mg/day among childbearing age
March of Dimes, 09, Br J Nut, 07
Global Recommendations
France
Japan
21
What happens with Iod in pregnancy?
• During pregnancy, hormonal changes
and metabolic demands result in
significant changes in thyroid
function
• Increased need for iodine supply due
to: (1) Increased production of TH &
maintain euthyroidism, (2) Elevated
renal clearance of iodine, and (3) the
fetoplacental acquisition of maternal
iodine and TH
Best Pract Res Clin Endocrinol Metab , 04, Thyroid, 2000
ID & maternal neonatal child outcomes: Test your info!
• 3rd cause of developmental problems in children
• ID disorders: Range from mild to moderate to severe
• Developmental quotient: Reduction in IQ scores to cretinism
• Severe ID during pregnancy: Congenital hypothyroidism resulting
in cretinism, an irreversible form of retarded growth and mental
retardation
Biological plausibility
• MID during pregnancy: Hypothyroxinemia in the mother
and/or elevated (TSH) levels in the fetus
• Related to mild and subclinical cognitive and
psychomotor deficits in neonates, infants and children
(Journal of Trace Elements in Medicine and Biology, 13)
• Before the fetal hypothalamic–pituitary–thyroid system becomes operative,
maternal T4 transfer is crucial for the fetus
• The fetal thyroid grows between 12 and 39 weeks of gestation, becomes active
in the 2nd trimester where demand for Iodine before 12-14 weeks
Now show them the evidence…Research
& studies